These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Miura J, Uchigata Y, Yokoyama H, Omori Y, Iwamoto Y. Diabetes Res Clin Pract; 1999 Aug; 45(1):41-9. PubMed ID: 10499884 [Abstract] [Full Text] [Related]
3. Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. van Ittersum FJ, de Man AM, Thijssen S, de Knijff P, Slagboom E, Smulders Y, Tarnow L, Donker AJ, Bilo HJ, Stehouwer CD. Nephrol Dial Transplant; 2000 Jul; 15(7):1000-7. PubMed ID: 10862638 [Abstract] [Full Text] [Related]
4. Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Tarnow L, Kjeld T, Knudsen E, Major-Pedersen A, Parving HH. Diabetologia; 2000 Jun; 43(6):794-9. PubMed ID: 10907125 [Abstract] [Full Text] [Related]
5. Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SL, Gibson SP, Khatoon A, MacDonald F, Rowe BR, Dunger DB, Dean JD, Davies SJ, Webber J, Smith PR, Mackin P, Marshall SM, Adu D, Morris PJ, Todd JA, Barnett AH, Boulton AJ, Bain SC. Diabetologia; 1996 Sep; 39(9):1108-14. PubMed ID: 8877296 [Abstract] [Full Text] [Related]
6. Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Barnas U, Schmidt A, Illievich A, Kiener HP, Rabensteiner D, Kaider A, Prager R, Abrahamian H, Irsigler K, Mayer G. Diabetologia; 1997 Mar; 40(3):327-31. PubMed ID: 9084972 [Abstract] [Full Text] [Related]
7. [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. Buraczyńska M, Ksiazek P, Łopatyński J, Spasiewicz D, Nowicka T, Ksiazek A. Pol Arch Med Wewn; 2002 Aug; 108(2):725-30. PubMed ID: 12476891 [Abstract] [Full Text] [Related]
8. [The significance of candidate genes' polymorphism in the development of diabetic nephropathy]. Grzeszczak W, Zukowska-Szczechowska E. Wiad Lek; 1998 Aug; 51 Suppl 2():11-23. PubMed ID: 9686528 [Abstract] [Full Text] [Related]
9. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. Ahluwalia TS, Ahuja M, Rai TS, Kohli HS, Bhansali A, Sud K, Khullar M. DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684 [Abstract] [Full Text] [Related]
10. Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Fradin S, Goulet-Salmon B, Chantepie M, Grandhomme F, Morello R, Jauzac P, Reznik Y. Diabetes Metab; 2002 Feb; 28(1):27-32. PubMed ID: 11938025 [Abstract] [Full Text] [Related]
11. Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus. Ilić V, Ilić M, Soldatović I, Popović S, Magić Z. Vojnosanit Pregl; 2014 Jul; 71(7):627-33. PubMed ID: 25109108 [Abstract] [Full Text] [Related]
12. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients]. Moleda P, Majkowska L, Safranow K, Adler G, Goracy I. Przegl Lek; 2007 Jul; 64(3):134-9. PubMed ID: 17941464 [Abstract] [Full Text] [Related]
13. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy. Wong TY, Szeto CC, Chow KM, Chan JC, Li PK. Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175 [Abstract] [Full Text] [Related]
14. Comments to: Tarnow L, Kjeld T, Knudsen E et al. (2000) lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in type I diabetic patients. Diabetologia 43: 794-799. Soltész G, Rózsai B. Diabetologia; 2001 Apr; 44(4):520. PubMed ID: 11357488 [No Abstract] [Full Text] [Related]
16. [Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes]. Mosorjáková D, Kyslanová L, Kozárová M, Tkác I. Vnitr Lek; 2002 Aug; 48(8):749-54. PubMed ID: 12425206 [Abstract] [Full Text] [Related]
17. Genetic variations associated with diabetic nephropathy and type II diabetes in a Japanese population. Maeda S, Osawa N, Hayashi T, Tsukada S, Kobayashi M, Kikkawa R. Kidney Int Suppl; 2007 Aug; (106):S43-8. PubMed ID: 17653210 [Abstract] [Full Text] [Related]
18. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy. Orisio S. J Nephrol; 1999 Aug; 12(1):9-17. PubMed ID: 10202997 [Abstract] [Full Text] [Related]
19. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. Eroglu Z, Cetinkalp S, Erdogan M, Kosova B, Karadeniz M, Kutukculer A, Gunduz C, Tetik A, Topcuoglu N, Ozgen AG, Tuzun M. J Diabetes Complications; 2008 Aug; 22(3):186-90. PubMed ID: 18413162 [Abstract] [Full Text] [Related]
20. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kimura H, Gejyo F, Suzuki Y, Suzuki S, Miyazaki R, Arakawa M. Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]